In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV).

For decades, mainstream culture has associated psychedelics with impairing the mind rather than improving it. But advocates, researchers and officials are starting to paint a different picture—that substances including magic mushrooms, mescaline, LSD and MDMA can actually help treat serious mental health issues.

Shadd Dales is joined by career brain researchers and husband-wife team behind Tessellate, a project designed to advance development of mental health psychedelic therapeutics.

Repeated use of small quantities of the psychedelic substance psilocybin can improve mood and mental health, a new study suggests.

Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing psychedelic therapies.

Meet Dr. Rochelle and Dr. Dustin Hines, the husband and wife team trailblazing the future of mental health therapeutics from their lab located at The University of Nevada Las Vegas (UNLV). Both armed with PhD's (University of British Columbia) and extensive post- doctoral training (Tufts University School of Medicine) in neuroscience, Dustin and Rochelle have worked at the interface of academia and industry over their combined 40 plus year careers.

Research by a team of neuroscientists from the University of Nevada, Las Vegas has shown that it is possible to identify the molecular mechanisms underlying a host of adverse symptoms associated with unique subtypes of neurodevelopmental disorders. This work could one day improve the lives of millions of people worldwide.

Psychedelic drugs such as psilocybin, LSD and mescaline are illegal in most of the country, considered Class 1 drugs by the federal government.